GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Shen Lian Biomedical Corp (SHSE:688098) » Definitions » Total Equity

Shanghai Shen Lian Biomedical (SHSE:688098) Total Equity : ¥1,503.9 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Shen Lian Biomedical Total Equity?

Shanghai Shen Lian Biomedical's total equity for the quarter that ended in Mar. 2024 was ¥1,503.9 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Shanghai Shen Lian Biomedical Total Equity Historical Data

The historical data trend for Shanghai Shen Lian Biomedical's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Shen Lian Biomedical Total Equity Chart

Shanghai Shen Lian Biomedical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,281.30 1,396.29 1,472.99 1,496.87 1,507.07

Shanghai Shen Lian Biomedical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,513.10 1,474.77 1,521.82 1,507.07 1,503.94

Shanghai Shen Lian Biomedical Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Shanghai Shen Lian Biomedical's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=1593.994-86.926
=1,507.1

Shanghai Shen Lian Biomedical's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=1594.149-90.206
=1,503.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Shen Lian Biomedical Total Equity Related Terms

Thank you for viewing the detailed overview of Shanghai Shen Lian Biomedical's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Shen Lian Biomedical (SHSE:688098) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Shen Lian Biomedical Corp (SHSE:688098) » Definitions » Total Equity
Comparable Companies
SHSE:688426 SHSE:688253 SZSE:002286 SHSE:688399 SHSE:688265 SHSE:688767 SZSE:300966 SZSE:301258 SZSE:002873 SZSE:000518 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 48, Jiangchuan East Road, Minhang District, Shanghai, CHN, 200241
Website
http://www.slbio.com.cn
Shanghai Shen Lian Biomedical Corp is engaged in the development, production and sales of veterinary biological products.
Executives
Ma Gui Jun Core technical personnel
Gao Yan Chun senior management

Shanghai Shen Lian Biomedical (SHSE:688098) Headlines

No Headlines